Activation of STAT3/HIF-1α/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTEN

Biochimica Et Biophysica Acta. General Subjects
Safiyeh Aghazadeh, Razieh Yazdanparast

Abstract

Resistance to the HER2-targeted antibody trastuzumab remains to be a major clinical challenge in the treatment of HER2-positive breast cancer. Hyper-activation of STAT3 is proposed to be a predictive biomarker of trastuzumab resistance. However, the precise mechanism(s) remains poorly defined. Evidence is emerging that HIF-1α, a central downstream element of STAT3 pathway, serves a pivotal role in the complex signaling network with subsequent diverse cellular events. We have established trastuzumab resistant SKBR3 cells (SKBR3-TR). The cell viability, apoptosis as well as western blot, siRNA transfection and co-immunoprecipitation assays were performed to evaluate the involvement of STAT3/HIF-1α in modulation of trastuzumab resistance. We found that in SKBR3-TR cells and conditioned medium-treated parental cells, constitutive phosphorylated STAT3 coincided with prominent up-regulation of HIF-1α which was accompanied with PTEN attenuation. Moreover, the inhibition of STAT3 activation by Stattic and/or genetically STAT3 knocking down decreased HIF-1α level in SKBR3-TR cells. Additionally, treatment with Stattic and/or STAT3 siRNA engendered the up-regulation of PTEN protein in STAT3-inhibited resistant cells. Restoration of PTEN ...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P CarterH M Shepard
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Mar 1, 2002·Internal Medicine·Gregg L Semenza
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Aug 18, 2004·Biochemical Pharmacology·Eun-Jin YeoJong-Wan Park
Oct 29, 2004·The American Journal of Pathology·Charles V Clevenger
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nills DiazCarlos A Muro-Cacho
Feb 7, 2006·Cancer Letters·Rita Nahta, Francisco J Esteva
Apr 29, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ruishan WangHuaxi Xu
Sep 2, 2006·Journal of Mammary Gland Biology and Neoplasia·Ali Badache, Anthony Gonçalves
Sep 18, 2007·Nature Medicine·Teresa PalomeroAdolfo A Ferrando
Jan 12, 2008·Biochimica Et Biophysica Acta·Reinhard DeppingMatthias Köhler
Jan 30, 2008·Cell Research·Khandaker Al Zaid Siddiquee, James Turkson
May 6, 2008·Cell·Leonardo SalmenaPier Paolo Pandolfi
Nov 6, 2008·Experimental & Molecular Medicine·Joo Eun JungMyung Hee Chung
Apr 16, 2013·The Journal of Biological Chemistry·Kelly A WhelanMauricio J Reginato
Sep 23, 2014·Trends in Biochemical Sciences·Chong Sun, René Bernards
Oct 25, 2014·Nature Reviews. Cancer·Hua YuRichard Jove
Nov 19, 2015·Trends in Pharmacological Sciences·Chengguang ZhaoGuang Liang
Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Akram SadeghiriziSafiyeh Aghazadeh

❮ Previous
Next ❯

Citations

Nov 4, 2017·International Journal of Molecular Sciences·Andrea NicoliniAngelo Carpi
Mar 29, 2018·Cellular & Molecular Biology Letters·Michaela GaloczovaBorivoj Vojtesek
May 31, 2019·International Journal of Molecular Sciences·Kyoko Inagaki-Ohara
Aug 23, 2020·International Journal of Molecular Sciences·Bor-Ren HuangDah-Yuu Lu
May 18, 2019·Cell Death and Differentiation·Qinjie WengQiaojun He
Apr 7, 2019·Scientific Reports·Anna BarkovskayaHarri M Itkonen
Dec 6, 2020·Cancer Letters·Courtney E McAleeseRodney F Minchin
Feb 19, 2021·Expert Opinion on Investigational Drugs·Matteo SantoniNicola Battelli
Feb 15, 2018·Archives of Biochemistry and Biophysics·Leila ShahriyaryAli Akbar Saboury

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.